Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - olanzapine -

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - olanzapine -

Singapore - English - HSA (Health Sciences Authority)

sa dental supply pte ltd - dental - the endo motor is for use by dentists with dental root canal instruments in continuous rotation and in reciprocating movement with integrated apex locator (endometric length determination).

Singapore - English - HSA (Health Sciences Authority)

sa dental supply pte ltd - dental - raypex6 is microprocessor controlled device used for root canal length determination to facilitate the process in root canal treatment.

Singapore - English - HSA (Health Sciences Authority)

sa dental supply pte ltd - dental - the vdw silver reciproc is designed for use by dentists for use with dental root canal instruments in continuous rotation and in reciprocating movement.

United States - English - NLM (National Library of Medicine)

boehringer ingelheim pharmaceuticals, inc. - nevirapine (unii: 99dk7fvk1h) (nevirapine - unii:99dk7fvk1h) - nevirapine 400 mg - viramune xr is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (hiv-1) infection in adults and pediatric patients 6 years of age or older with a body surface area (bsa) of 1.17 m2 or greater [see clinical studies (14.1, 14.2)] . limitations of use: - adult females with cd4+ cell counts greater than 250 cells/mm3 or - adult males with cd4+ cell counts greater than 400 cells/mm3 [see warnings and precautions (5.1)]. viramune xr is contraindicated: - in patients with moderate or severe (child-pugh class b or c, respectively) hepatic impairment [see warnings and precautions (5.1) and use in specific populations (8.7)] . - for use as part of occupational and non-occupational post-exposure prophylaxis (pep) regimens [see warnings and precautions (5.1)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to nevirapine during pregnancy. healthcare providers are encouraged to register pat

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - nevirapine (unii: 99dk7fvk1h) (nevirapine - unii:99dk7fvk1h) - nevirapine 400 mg - viramune xr is indicated for use in combination with other antiretroviral agents for the treatment of hiv-1 infection in adults and in children 6 to less than 18 years of age [see clinical studies (14.1, 14.2) ]. additional important information regarding the use of viramune xr for the treatment of hiv-1 infection: - based on serious and life-threatening hepatotoxicity observed in controlled and uncontrolled trials, nevirapine should not be initiated in adult females with cd4+ cell counts greater than 250 cells/mm3 or in adult males with cd4+ cell counts greater than 400 cells/mm3 unless the benefit outweighs the risk [see boxed warning and warnings and precautions (5.1) ]. - the 14-day lead-in period with immediate-release viramune dosing must be strictly followed; it has been demonstrated to reduce the frequency of rash [see dosage and administration (2.5) and warnings and precautions (5.2) ]. - if rash persists beyond the 14-day lead-in period with immediate-release viramune, do not begin dosing with

Australia - English - Department of Health (Therapeutic Goods Administration)

boehringer ingelheim pty ltd - nevirapine -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

boehringer ingelheim ltd - nevirapine - modified-release tablet - 400mg

Malta - English - Medicines Authority

koanaa healthcare limited - irinotecan hydrochloride, trihydrate - concentrate for solution for infusion - irinotecan hydrochloride trihydrate 40/2 milligram(s)/millilitre - antineoplastic agents